Skip to content

Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite

Evaluation of Bone Quantity in Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite as Sole Grafting Material in Patients With Atrophied Posterior Maxillary Ridge

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02577289
Enrollment
18
Registered
2015-10-16
Start date
2015-07-31
Completion date
2017-12-31
Last updated
2015-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophied Posterior Maxillary Ridge

Keywords

simultaneous implantation, Dental implant, Open sinus Lifting, PRF, platelet rich fibrin (PRF)

Brief summary

Evaluation of bone quantity in open sinus lift technique with space maintaining using platelet rich fibrin (PRF) as sole augmentation material versus nano crystalline hydroxyapatite with simultaneous placing of implants.

Detailed description

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation using platelet rich fibrin (PRF) versus Nano-crystalline Hydroxyapatite as sole grafting material in patients with atrophied posterior maxillary ridge which provides a new modality for treatment of patients with atrophied posterior maxillary ridge with least cost and a much easier way using platelet rich fibrin (PRF) as substitution to bone graft

Interventions

PROCEDUREEvaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)

• The sinus cavity will be augmented with bone graft ( Nano crystalline hydroxyapatite)

PROCEDUREEvaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)

platelet rich fibrin (PRF) as sole grafting material in created space (PRF)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients should be seeking for implant supported prosthesis in posterior maxilla bilaterally * All patients should have atrophied posterior maxillary ridge with the maximum height of the alveolar bone is from 3 mm to 5 mm

Exclusion criteria

* Ongoing steroid therapy; * Uncontrolled diabetes; * Recent cardiovascular diseases; * Inflammation of the maxillary sinus; * Previous radiant therapy for neoplastic pathologies * Patient who have had previous failed sinus augmentation, or exhibited pathological finding or had a history of maxillary sinus disease or operations or whose medical condition might increase surgical risk of the research protocol were excluded.

Design outcomes

Primary

MeasureTime frameDescription
The amount of new bone formation the sinus cavity using CBCT6 monthsthe amount of new bone formation of PRF in comparison with Nano-crystalline hydroxyappetite in millimeters using cone beam computed tomography (CBCT)

Countries

Egypt

Contacts

Primary ContactWaleed M. Nour El Din, BDS
waleed_nour@live.com+2-01001448723
Backup ContactHesham Abdel Hakm, Professor
surgery@dentistry.cu.edu.eg+2-01156096060

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026